Dataset Information

A targeted promotional DVD fails to improve Maori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.

ABSTRACT:

Background

New Zealand's Bowel Screening Pilot (BSP) used a mailed invitation to return a faecal immunochemical test. As a pilot it offered opportunities to test interventions for reducing ethnic inequities in colorectal cancer screening prior to nationwide programme introduction. Small media interventions (e.g. educational material and DVDs) have been used at both community and participant level to improve uptake. We tested whether a DVD originally produced to raise community awareness among the M?ori population would have a positive impact on participation and reduce the proportion of incorrectly performed tests (spoiled kits) if mailed out with the usual reminder letter.

Methods

The study was a parallel groups pseudo-randomised controlled trial. Over 12?months, all M?ori and Pacific ethnicity non-responders four weeks after being mailed the test kit were allocated on alternate weeks to be sent, or not, the DVD intervention with the usual reminder letter. The objective was to determine changes in participation and spoiled kit rates in each ethnic group, determined three months from the date the reminder letter was sent. Participants and those recording the outcomes (receipt of a spoiled or non-spoiled test kit) were blinded to group assignment.

Results

2333 M?ori and 2938 Pacific people participated (11 withdrew). Those who were sent the DVD (1029 M?ori and 1359 Pacific) were less likely to participate in screening than those who were not (1304 M?ori and 1579 Pacific). Screening participation was reduced by 12.3% (95% CI 9.1-15.5%) in M?ori (13.6% versus 25.9%) and 8.3% (95% CI 5.8-10.8%) in Pacific (10.1% versus 18.4%). However, spoiled kit rates (first return) were significantly higher among those not sent the DVD (33.1% versus 12.4% in M?ori and 42.1% versus 21.9% in Pacific).

Conclusion

The DVD sent with the reminder letter to BSP non-responders reduced screening participation to an extent that more than offset the lower rate of spoiled kits.

Trial registration

Australia and New Zealand Clinical Trials Registry ACTRN12612001259831 . Registered 30 November 2013.

SUBMITTER: Bartholomew K

PROVIDER: S-EPMC6734461 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.

Bartholomew Karen K Zhou Lifeng L Crengle Sue S Buswell Elizabeth E Buckley Anne A Sandiford Peter P

BMC public health 20190909 1

<h4>Background</h4>New Zealand's Bowel Screening Pilot (BSP) used a mailed invitation to return a faecal immunochemical test. As a pilot it offered opportunities to test interventions for reducing ethnic inequities in colorectal cancer screening prior to nationwide programme introduction. Small media interventions (e.g. educational material and DVDs) have been used at both community and participant level to improve uptake. We tested whether a DVD originally produced to raise community awareness ...[more]

PMID: 31500594

Similar Datasets

Project description:Interventions: The intervention consists of a delay of 8 weeks in commencing the standard Active Follow (AF) pathway invitees to bowel screening who have not returned a test kit within 4 weeks of being sent an invitation letter. The standard AF service consists of the following. Eligible individuals are identified and extracted from the Bowel Screening Pilot register. This data is inserted into an Access (Registered Trademark) database. The database is available to the team of Community coordinators who carry out the AF activities. They use the database to filter the population according to the ethnicity that they serve. The Coordination Centre employs 0.4 FTE of Maori Community Coordinators, 0.4 FTE of Samoan/Other Pacific Coordinators and 0.9 FTE of Asian Coordinators. They phone the individuals and record the outcome of the calls. Key Performance Indicators set by the MOH require a minimum of 3 phone calls to be made within a 4 week period, one of which must be made after regular working hours. If a number appears to be invalid other data sources are searched for current contact details. These include the hospital systems, the Primary Health Organisation age/sex registers, the patient’s GP practice, and contacts the Community Coordinators have with their own communities. In the intervention group this active follow-up activity commences 12 weeks after being sent an invitation letter for bowel screening rather than 4 weeks after as in the control group. Primary outcome(s): The primary endpoint of the study is the overall difference in the participation rate of people in the intervention group compared with the control group, [For each invitee, the primary outcome will be measured at 8 weeks from the date at which they were randomly assigned to the group (and for the intervention group with delayed AF, it will measured prior to their receiving the AF service). ] Study Design: Purpose: Diagnosis; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy

Project description:In Aotearoa, New Zealand, the majority of cervical cancer cases occur in women who have never been screened or are under-screened. Wāhine Māori, Pacific and Asian women have the lowest rate of cervical screening. Self-sampling for human papillomavirus (HPV-SS) has been shown to increase participation in cervical cancer screening. A whole-of-system approach, driven by evidence in the most effective delivery of HPV-SS, is required to mitigate further widening of the avoidable gap in cervical screening access and outcomes between groups of women in Aotearoa. This single-arm feasibility and acceptability study of HPV self-sampling invited never- and under-screened (≥5 years overdue) 30-69-year-old women from general practices in Auckland, Aotearoa. Eligible women were identified by data matching between the National Cervical Programme (NCSP) Register and practice data. Focus groups were additionally held with eligible wāhine Māori, Asian and Pacific women to co-design new patient information materials. Questionnaires on HPV knowledge and post-test experience were offered to women. Our follow-up protocols included shared decision-making principles, and we committed to follow-up ≥90% of women who tested positive for HPV. Data matching identified 366 eligible never- and under-screened wāhine Māori, Pacific and Asian women in participating practices. We were only able to contact 114 women, and 17, during the discussion, were found to be ineligible. Identifying and contacting women overdue for a cervical screen was resource-intensive, with a high rate of un-contactability despite multiple attempts. We found the best uptake of self-sampling was at focus groups. Of the total 84 HPV-SS tests, there were five positive results (6%), including one participant with HPV18 who was found to have a cervical Adenocarcinoma at colposcopy. In our feasibility study, self-sampling was acceptable and effective at detecting HPV and preventing cervical cancer in under-screened urban wāhine Māori, Pacific and Asian women in Aotearoa. This is the first report of cervical Adenocarcinoma (Grade 1B) as a result of an HPV-18 positive self-sample in Aotearoa. We co-designed new patient information materials taking a health literacy and ethnicity-specific approach. This work provides policy-relevant information to the NCSP on the resources required to implement an effective HPV self-sampling programme to improve equity in national cervical cancer screening.